The expression of 4E-BP1 (Figure 1B) and its phosphorylated form (Figure 1C) increased stepwise from low grade gliomas (LGGs) to GBM compared to non-neoplastic cortical control brain tissue (CCBT). This evidence concerns the gene EIF4EBP1 and central nervous system cancer.